发明名称 Matrix metalloproteinase inhibitors
摘要 Compounds of the formula (I)where X is a -CO2H or -CONHOH group; Y and Z are independently sulphur or oxygen, at least one being sulphur; R1 is hydrogen, hydroxy, (C1-C6)alkyl, (C2-C6)alkenyl, or (C3-C8cycloalkyl; R2 is a (C1-C24)alkyl, phenyl(C1-C6)alkyl, or phenyl(C0-C6alkyl)O)C1-C6)alkyl, any of which may be optionally substituted by (C1-C6)alkyl, (C1-C6)alkoxy, halo or cyano (CN); R3 is the characterising side chain of a natural alpha-amino acid in which any functional groups may be protected, (C1-C6)alkyl which may be optionally substituted, or cycloalkyl(C1-C6)alkyl; R4 is hydrogen, (C1-C6)alkyl, phenyl(C1-C6)alkyl, optionally substituted phenyl or heteroaryl, or a group of formula -(Q-O)n-Q where Q is a straight or branched (C1-C6)alkyl, where n is an integer >1 and no continuous linear sequence of atoms in the group R4 is >12; or a salt, hydrate or solvate thereof. The compounds are useful for treating various medical conditions such as tissue breakdown and inflammation.
申请公布号 AU2512599(A) 申请公布日期 1999.09.20
申请号 AU19990025125 申请日期 1999.02.23
申请人 LEO PHARMACEUTICAL PRODUCTS LTD. A/S 发明人 METTE KNAK CHRISTENSEN
分类号 A61K31/405;A61K31/16;A61K31/195;A61K31/403;A61K31/404;A61K31/655;A61P1/02;A61P1/04;A61P17/06;A61P19/00;A61P19/02;A61P25/00;A61P27/02;A61P27/06;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07C327/42;C07C327/44;C07D209/20;C07D249/18;C07D317/36 主分类号 A61K31/405
代理机构 代理人
主权项
地址